CIDRAP newsletters options
Dec 1, 2009
(CIDRAP News) Decreasing pandemic flu activity and growing supplies of vaccine offer a window of opportunity for people to protect themselves from the virus, especially if the nation experiences a third wave of infections, Thomas Frieden, MD, director of the US Centers for Disease Control and Prevention (CDC) said today.
(CIDRAP News) The number of states with widespread pandemic flu activity dropped for the third week in a row, but the virus continued to take a heavy toll on children, with at least 27 more pediatric deaths reported the week of Nov 15 to 21, the US Centers for Disease Control and Prevention (CDC) said today.
Nov 30, 2009
(CIDRAP News) In a worrisome but not unexpected pandemic-related development, the US Centers for Disease Control and Prevention (CDC) said today that it is seeing a spike in serious pneumococcal disease, particularly in younger patients.
Nov 25, 2009
Nov 24, 2009
(CIDRAP News) – The era of cell-based influenza vaccine production in the United States seemed to move closer today as Novartis unveiled its new, nearly billion-dollar manufacturing plant in Holly Springs, N.C., but onshore production and marketing of cell-based vaccines remains a few years away.
ECDC: Norway mutation may affect receptor binding
Nov 20, 2009
(CIDRAP News) Health officials in Wales today announced the identification of a cluster of patients in a Cardiff hospital who are infected with oseltamivir-resistant pandemic H1N1 influenza.
(CIDRAP News) Pandemic H1N1 influenza activity is showing further signs of declining around the country but remains very widespread, the Centers for Disease Control and Prevention (CDC) reported today.
Nov 19, 2009
(CIDRAP News) Early experiences with pandemic vaccines in several countries suggest they have a similar safety profile to seasonal flu vaccines, an official from the World Health Organization (WHO) said today.
(CIDRAP News) Leaders of the US Senate Homeland Security Committee sharply critiqued the federal government's H1N1 vaccination strategy yesterday, saying health officials should have recommended targeting only the highest-risk groups as soon as the vaccine delays came to light.
Nov 18, 2009
(CIDRAP News) Federal officials, along with representatives from four vaccine companies, appeared before two US House of Representatives committees today to answer questions about why the nation hasn't stretched scarce pandemic vaccine supply with adjuvants and if a more federally directed distribution system might help vaccine get to more high-risk patients.
